| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| sodium fluoride | Injection, concentrated | 1 mg/mL | Anticipated | Available | Manufacturing | 1/12/2024 |
| acarbose | Tablet | 100 mg | Anticipated | Available | Manufacturing | 1/12/2024 |
| rasagiline mesilate | Tablet, uncoated | 1.56 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 1/12/2024 |
| testosterone enantate | Injection | 250 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 29/11/2024 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Anticipated | Available | Manufacturing | 29/11/2024 |
| topiramate | Tablet, film coated | 200 mg | Current | Limited Availability | Manufacturing | 29/11/2024 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 29/11/2024 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Resolved | Available | Manufacturing | 29/11/2024 |
| levothyroxine sodium | Tablet, uncoated | .075 mg | Resolved | Available | Manufacturing | 29/11/2024 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Resolved | Available | Manufacturing | 29/11/2024 |
| levothyroxine sodium | Tablet, uncoated | .2 mg | Resolved | Available | Manufacturing | 29/11/2024 |
| clonazepam | Tablet, uncoated | 2 mg | Resolved | Available | Manufacturing | 29/11/2024 |
| norethisterone~ethinylestradiol | Tablet, uncoated | 1 mg~36 microgram | Current | Limited Availability | Manufacturing | 29/11/2024 |
| metformin hydrochloride | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 29/11/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 29/11/2024 |
| nizatidine | Capsule | 300 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 29/11/2024 |
| chlorhexidine gluconate | Solution, irrigation | 30 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Anticipated | Available | Manufacturing | 28/11/2024 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| phenoxymethylpenicillin potassium | Tablet, film coated | 280 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| quetiapine fumarate | Tablet, film coated | 28.78 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| metoprolol succinate | Tablet, modified release | 190 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 21.75 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/11/2024 |
| ezetimibe~atorvastatin calcium trihydrate | Tablet, multilayer | 10 mg~21.7 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, multilayer | 43.4 mg~10 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| atorvastatin calcium trihydrate~ezetimibe | Tablet, multilayer | 86.8 mg~10 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/11/2024 |
| betahistine dihydrochloride | Tablet, uncoated | 16 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| cinacalcet hydrochloride | Tablet | 99.191 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| deferasirox | Tablet, film coated | 360 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| paracetamol | Tablet, modified release | 665 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 28/11/2024 |
| melatonin | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 28/11/2024 |
| lidocaine hydrochloride monohydrate | Injection, solution | 20 mg/mL | Resolved | Available | Manufacturing | 28/11/2024 |
| lidocaine hydrochloride monohydrate | Injection, solution | 10 mg/mL | Resolved | Available | Manufacturing | 28/11/2024 |
| verapamil hydrochloride | Tablet, modified release | 180 mg | Resolved | Available | Manufacturing | 28/11/2024 |
| clonazepam | Tablet, uncoated | .5 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| clarithromycin | Oral Liquid, powder for | 50 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 28/11/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Anticipated | Available | Manufacturing | 28/11/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Manufacturing | 28/11/2024 |
| pravastatin sodium | Tablet, uncoated | 40 mg | Current | Unavailable | Manufacturing | 28/11/2024 |
| norethisterone | Tablet, uncoated | 350 microgram | Current | Unavailable | Manufacturing | 27/11/2024 |
| gabapentin | Capsule, hard | 300 mg | Anticipated | Available | Manufacturing | 27/11/2024 |
| gentamicin | Injection, solution | 80 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| hydrochlorothiazide~valsartan | Tablet, film coated | 25 mg~320 mg | Resolved | Available | Manufacturing | 27/11/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Resolved | Available | Manufacturing | 27/11/2024 |
| betahistine dihydrochloride | Tablet | 24 mg | Current | Unavailable | Unexpected increase in consumer demand | 27/11/2024 |
| ezetimibe | Tablet | 10 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 27/11/2024 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| trimethoprim | Tablet, uncoated | 300 mg | Resolved | Available | Manufacturing | 27/11/2024 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 109 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 54.5 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 27.25 mg | Current | Unavailable | Manufacturing | 27/11/2024 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/11/2024 |
| Somatropin | Injection, powder for | 12 mg/mL | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 26/11/2024 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Anticipated | Available | Manufacturing | 26/11/2024 |
| tenofovir disoproxil maleate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Current | Unavailable | Manufacturing | 26/11/2024 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Anticipated | Available | Manufacturing | 26/11/2024 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Anticipated | Available | Manufacturing | 26/11/2024 |
| ropinirole hydrochloride | Tablet, film coated | .285 mg | Anticipated | Available | Manufacturing | 26/11/2024 |
| aciclovir | Injection, solution | 25 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 26/11/2024 |
| aciclovir | Injection, solution | 25 mg/mL | Current | Unavailable | Manufacturing | 26/11/2024 |
| oseltamivir phosphate | Capsule, hard | 98.524 mg | Resolved | Available | Unexpected increase in consumer demand | 26/11/2024 |
| olmesartan medoxomil~amlodipine besilate | Tablet, film coated | 40 mg~6.94 mg | Current | Unavailable | Unexpected increase in consumer demand | 26/11/2024 |
| dasatinib | Tablet, film coated | 50 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 26/11/2024 |
| heparin sodium | Injection, solution | 5000 IU/mL | Current | Unavailable | Manufacturing | 26/11/2024 |
| ciprofloxacin hydrochloride | Tablet, film coated | 873.32 mg | Current | Limited Availability | Manufacturing | 26/11/2024 |
| acetylcysteine | Injection, concentrated | 2 g | Anticipated | Available | Manufacturing | 25/11/2024 |
| fluticasone furoate | Spray, suspension | 27.5 microgram | Resolved | Available | Unexpected increase in consumer demand | 25/11/2024 |
| amoxicillin trihydrate~potassium clavulanate | Suspension, powder for | 28.7 mg/mL~7.45 mg/mL | Resolved | Available | Manufacturing | 25/11/2024 |
| ibuprofen~codeine phosphate hemihydrate | Tablet, film coated | 200 mg~12.8 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 25/11/2024 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Current | Limited Availability | Manufacturing | 25/11/2024 |
| dexamethasone sodium phosphate | Injection, solution | 4.37 mg/mL | Resolved | Available | Manufacturing | 25/11/2024 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 125 mg~33.75 mg~200 mg | Anticipated | Available | Manufacturing | 25/11/2024 |
| voriconazole | Injection, powder for | 200 mg | Current | Unavailable | Manufacturing | 25/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 25/11/2024 |
| irbesartan~hydrochlorothiazide | Tablet, film coated | 300 mg~25 mg | Current | Unavailable | Manufacturing | 25/11/2024 |
| nebivolol hydrochloride | Tablet | 10.9 mg | Resolved | Available | Manufacturing | 25/11/2024 |
| nebivolol hydrochloride | Tablet | 1.363 mg | Resolved | Available | Manufacturing | 25/11/2024 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 25/11/2024 |
| olanzapine | Tablet, uncoated | 2.5 mg | Anticipated | Available | Manufacturing | 25/11/2024 |
| heparin sodium | Injection, solution | 1000 IU/mL | Current | Limited Availability | Manufacturing | 25/11/2024 |
2024年12月2日